Run Sheng Jiang

Presidente en WALVAX BIOTECHNOLOGY CO., LTD. .

Fortuna: 3 M $ al 31/05/2024

67 años

Health Technology

Perfil

Run Sheng Jiang ocupa el cargo de Presidente y Director de Walvax Biotechnology Co., Ltd. y Presidente de Shanghai Zerun Biotech Co. (una filial de Walvax Biotechnology Co., Ltd.).

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
WALVAX BIOTECHNOLOGY CO., LTD. CLASS A 0.06%	30/06/2023	930 000 ( 0.06% )	2 M $	31/05/2024
WALVAX BIOTECHNOLOGY CO., LTD. 1.64%	30/09/2023	773 437 ( 1.64% )	1 M $	31/05/2024

Cargos activos de Run Sheng Jiang

Empresas	Cargo	Inicio
WALVAX BIOTECHNOLOGY CO., LTD.	Presidente	22/06/2016
Shanghai Zerun Biotechnology Co., Ltd. Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.	Presidente	-

Todos los cargos activos de Run Sheng Jiang

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Run Sheng Jiang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
WALVAX BIOTECHNOLOGY CO., LTD.	Health Technology

Empresas privadas	1
Shanghai Zerun Biotechnology Co., Ltd. Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.	Health Technology